Advancing precision medicine
Webinar title: "Advancing precision medicine: Prognostic biomarkers for pediatric Crohn's disease"
In this webinar, Dr. Andres Hurtado-Lorenzo presents findings from a Crohn's & Colitis Foundation study to identify predictive biomarkers related to both prognosis of complications and therapy response outcomes in pediatric Crohn's disease.
Watch the webinar to learn more about:
- Their use of data from multiomics studies, such as RNAseq and plasma proteomics, to develop a high performance, prognostic protein signature for Crohn's complications.
- How they used Olink and machine learning to develop a prognostic protein panel to predict development of fibrosis with an accuracy of 84%, and a 3-protein signature that predicts response to anti-TNF therapy with an accuracy of 90%.
- Development of a custom panel which as been further tested and verified as an effective tool for future management of Crohn's disease.
Dr. Andres Hurtado-Lorenzo
VP Translational Research at the Crohn's and Colitis Foundation